GE has teamed up with Zenith Technologies to implement automation across its single-use and modular bioprocessing technologies.
GE Healthcare has pledged its support and technology to a national £55m ($86m) Cell Therapy manufacturing centre in Stevenage, UK, set to launch in 2017.
GE Healthcare and iBio are in talks about future projects after confirming they are working on a plant-based vaccine manufacturing site for Brazilian drugmaker Fiocruz/Bio-Manguinhosin.
GE Healthcare has started designing a vaccine manufacturing facility for an unnamed drug company, just days after expanding its collaboration with plant-cell production technology firm iBio.
BGI has joined with GE Healthcare in a multi-year push to advance stem cell-derived assays for drug discovery and toxicology.
GE Healthcare has announced plans to buy US production tech firm Xcellerex, continuing its efforts to build its biomanufacturing offering.
GE Healthcare to invest in biomanufacturing tech
GE Healthcare will expand its range of biomanufacturing technologies under a new oncology-focused investment project.
iBio, GE partner to work on plant-based production tech
iBio, CMB and GE Healthcare are collaborating on developing and marketing biopharm production systems, including plant-based expression technology.
GE unveils modular approach to facility validation
GE Healthcare hopes its new modular validation platform (MVP) will change the way drugmakers think about how they create new plants and bring existing manufacturing facilities up to code.
FDA guidance on GE animal drug production
The US Food and Drug Administration (FDA) has issued draft guidance for the use of genetically engineered (GE) animals to produce drugs.
GE pockets single-use biotech firm
GE Healthcare has snapped up specialist in disposable manufacturing
technologies Wave Biotech, adding a host of new products and
services for the biopharmaceutical manufacturing sector to its
Mar Cor buys dialysis water business from GE
Mar Cor Purification has bought GE Water and Process Technologies'
dialysis water business for $30.6m (€22.8m) to become the largest
provider of dialysis water in the US, and plans to expand their
presence in industrial life...
New cost-cutting polymers invented
General Electric (GE) has launched a range of
ultra-high-performance plastics that it claims will answer the need
for cost-effective injection moldable resin.
GE Healthcare promises cheaper lab servicing
GE Healthcare has launched a new contract offering that it claims
will cut the cost of running the service operations in life science
R&D labs by up to 20 per cent, at a time when pharma and
biotech firms are facing intense cost...
Roche, GE link up on personalised medicine
Roche and GE Healthcare have entered into a collaboration aimed at
developing a personalised care strategy for patients with
GE launches AKTA for process development
GE Healthcare has expanded its AKTA range of chromatography amd
filtration systems with the launch of AKTAcrossflow for membrane
selection and process development at the research scale.
MAb purification products launched by GE
GE Healthcare has launched two new products designed to meet
growing industry needs for the purification of monoclonal
antibodies, one of the fastest growing drug classes in the drug
GE to buy Ionics for $1.1bn
GE Infrastructure, a business unit of General Electric, is to
acquire US water purification and wastewater treatment company
Ionics for around $1.1 billion (€813m), plus the assumption of
Amersham: Its General Electric
General Electric is the company offering to buy Amersham of the UK,
it was confirmed today. The US group is offering £5.7 billion for
the life sciences group, and said it has no plans to hive off